Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate Implant With Soft Tissue Augmentation
NCT02864862Phase 4Completed
- Sponsor
- UTHealth Houston
- Start
- Oct 2016
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (3 arms), sponsored by UTHealth Houston. Primary endpoint: Change in Ridge Dimension at 12 months. Started Oct 2016; status: completed.
Beyond the preview
Go deeper on NCT02864862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02864862.